Cargando…
Genomic advances and their impact on clinical trial design
Medical treatment for patients has historically been based on two primary elements: the expected outcome for the patient, and the ability of treatment to improve the expected outcome. The advance in genomic technologies has the potential to change this paradigm and add substantial value to current m...
Autores principales: | Mandrekar, Sumithra J, Sargent, Daniel J |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2717395/ https://www.ncbi.nlm.nih.gov/pubmed/19638184 http://dx.doi.org/10.1186/gm69 |
Ejemplares similares
-
The Direct Assignment Option as a Modular Design Component: An Example for the Setting of Two Predefined Subgroups
por: An, Ming-Wen, et al.
Publicado: (2015) -
Missing tumor measurement (TM) data in the search for alternative TM-based endpoints in cancer clinical trials
por: An, Ming-Wen, et al.
Publicado: (2019) -
Modeling tumor measurement data to predict overall survival (OS) in cancer clinical trials
por: Ou, Fang-Shu, et al.
Publicado: (2021) -
Physician-Reported Experience and Understanding of Adverse Event Attribution in Cancer Clinical Trials
por: Le-Rademacher, Jennifer G., et al.
Publicado: (2019) -
Impact of the COVID-19 Pandemic on Cancer Clinical Trials
por: Boughey, Judy C., et al.
Publicado: (2021)